ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
675
|
193K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
8 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
675
|
193K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
9 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
675
|
193K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
9 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
675
|
193K
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
2 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
RickyH
|
1.0K |
517K |
17 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1.0K
|
517K
|
17
|
|
ASX - By Stock
|
AVH |
Re:
Why AVH is a bargain right now / chart
|
|
RickyH
|
127 |
61K |
10 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
127
|
61K
|
10
|
|
ASX - By Stock
|
AVH |
Re:
Why AVH is a bargain right now / chart
|
|
RickyH
|
127 |
61K |
14 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
127
|
61K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
RickyH
|
93 |
35K |
12 |
30/01/21 |
30/01/21 |
ASX - By Stock
|
93
|
35K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
11 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
675
|
193K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
RickyH
|
221 |
66K |
2 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
221
|
66K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
RickyH
|
221 |
66K |
15 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
221
|
66K
|
15
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
5 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
RickyH
|
1.0K |
502K |
3 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
1.0K
|
502K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
RickyH
|
1.0K |
502K |
6 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
1.0K
|
502K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
RickyH
|
1.0K |
502K |
15 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
1.0K
|
502K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
RickyH
|
763 |
324K |
13 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
763
|
324K
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
13 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
11 |
10/01/21 |
10/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
10 |
10/01/21 |
10/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
3 |
09/01/21 |
09/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
RickyH
|
10K |
3.0M |
15 |
09/01/21 |
09/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
5 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
675
|
193K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Do you still think Mesoblast will be the next CSL?
|
|
RickyH
|
155 |
66K |
7 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
155
|
66K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
RickyH
|
192 |
86K |
2 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
192
|
86K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
RickyH
|
192 |
86K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
192
|
86K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
23 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
13 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
9 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
16 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
26 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
16 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
RickyH
|
1.0K |
418K |
40 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
6 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
675
|
193K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
9 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
675
|
193K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
4 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
675
|
193K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
42 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
675
|
193K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
RickyH
|
572 |
251K |
10 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
572
|
251K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment
|
|
RickyH
|
272 |
109K |
16 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
272
|
109K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
RickyH
|
572 |
251K |
11 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
572
|
251K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
RickyH
|
675 |
193K |
22 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
675
|
193K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
RickyH
|
572 |
251K |
13 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
572
|
251K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
RickyH
|
572 |
251K |
28 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
251K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
RickyH
|
811 |
334K |
10 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
811
|
334K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
RickyH
|
811 |
334K |
84 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
811
|
334K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
13 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
392
|
158K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
35 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
392
|
158K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
RickyH
|
3.1K |
1.4M |
2 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
RickyH
|
3.1K |
1.4M |
8 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
More analysis less fighting
|
|
RickyH
|
7 |
3.2K |
8 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
7
|
3.2K
|
8
|
|